September 3, 2008 - US Oncology Inc. launched Innovent Oncology, a service division that offers a first-time opportunity for oncologists and health plans to work together through integrated programs designed specifically for the complexity of cancer care.

With a focus on supporting the entire patient cancer care continuum, Innovent Oncology reportedly offers payers and oncologists solutions that combine evidence-based treatment guidelines, patient support services and advance care planning to improve clinical outcomes while addressing costs.
The need to contain cancer costs while continuing to advance clinical science and care is growing more urgent every year. Cancer treatment costs are expected to exceed $100 billion by 2010 with absenteeism, lost productivity and other costs expected to exceed $300 billion in that same year. Every year 1.5 million people in the U.S. are diagnosed with cancer. Each of the 300 different cancer types requires its own approach to diagnosis and treatment, while a host of emerging therapies are creating even more treatment options. The associated costs are nearing a breaking point that threatens patient access to care said the company.

Innovent Oncology offers a comprehensive program addressing the primary cancer care cost drivers including: the wide variation in treatment selection, side effects that prompt ER visits and hospitalizations and ineffective interventions near the end of life.

The core services offered include:

-- Level I Pathways: Physician-developed, evidence-based pathways that reduce treatment variability and resulting costs while providing a platform for standardization, outcomes measurement and ongoing peer review.

-- Patient Support Services: An oncology-specific disease management program that increases treatment compliance, helps patients monitor and manage side effects and reduces unnecessary ER visits and hospitalizations.

-- Advance Care Planning: Transition care planning and implementation that prepares patients early in their care process for potential end-of-life issues by addressing clinical, social, financial and spiritual needs.

For more information: www.usoncology.com, www.innoventoncology.com


Related Content

Feature | Oncology Information Management Systems (OIMS)

August 2, 2022 — The oncology information systems market is projected to be worth $2.59 Bn by 2022 and is expected to ...

Time August 02, 2022
arrow
News | Artificial Intelligence

May 31, 2022 — Patient trust is not a barrier to artificial intelligence (AI) adoption by medical imaging professionals ...

Time May 31, 2022
arrow
News | Radiation Therapy

May 18, 2022 — RaySearch announced that the treatment control system RayCommand is in clinical use at the innovative ...

Time May 18, 2022
arrow
News | Artificial Intelligence

May 17, 2022 — Edgility, Inc. launched EdgeAi as healthcare's first operationally embedded AI with Explainability ...

Time May 17, 2022
arrow
News | Lung Imaging

May 13, 2022 — Median Technologies announced that the company has received feedback from the United States Food and Drug ...

Time May 13, 2022
arrow
News | Remote Viewing Systems

March 18, 2022 — Electronic Caregiver, a national digital health technology and services company, will debut Addison ...

Time March 18, 2022
arrow
Videos | Oncology Information Management Systems (OIMS)

An example of the Varian Noona software used by clinicians to interface with oncology patients demonstrated at the ...

Time November 12, 2021
arrow
News | Oncology Information Management Systems (OIMS)

October 22, 2021 — The latest versions of RayStation (11A) and RayCare (5A) were released in May 2021. A new feature in ...

Time October 22, 2021
arrow
News | Radiation Oncology

August 30, 2021 — RaySearch Laboratories AB (publ) will be showcasing the latest oncology software innovations at ESTRO ...

Time August 30, 2021
arrow
News | Oncology Information Management Systems (OIMS)

June 28, 2021 — RaySearch Laboratories AB announced an extension of its relationship with Centre hospitalier ...

Time June 28, 2021
arrow
Subscribe Now